DK497076A - - Google Patents

Info

Publication number
DK497076A
DK497076A DK497076A DK497076A DK497076A DK 497076 A DK497076 A DK 497076A DK 497076 A DK497076 A DK 497076A DK 497076 A DK497076 A DK 497076A DK 497076 A DK497076 A DK 497076A
Authority
DK
Denmark
Application number
DK497076A
Other languages
Danish (da)
Other versions
DK142324B (da
DK142324C (ja
Inventor
W Bebenburg
N Schulmeyer
V Jakovlev
Original Assignee
Deutsche Gold Und Silber Scheide Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsche Gold Und Silber Scheide Anstalt filed Critical Deutsche Gold Und Silber Scheide Anstalt
Publication of DK497076A publication Critical patent/DK497076A/da
Publication of DK142324B publication Critical patent/DK142324B/da
Application granted granted Critical
Publication of DK142324C publication Critical patent/DK142324C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK497076AA 1975-11-04 1976-11-03 Analogifremgangsmåde til fremstilling af pyrido-(2,3-f)-(1,4)-diazepiner. DK142324B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT837275 1975-11-04
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (3)

Publication Number Publication Date
DK497076A true DK497076A (ja) 1977-05-05
DK142324B DK142324B (da) 1980-10-13
DK142324C DK142324C (ja) 1981-03-02

Family

ID=3604891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK497076AA DK142324B (da) 1975-11-04 1976-11-03 Analogifremgangsmåde til fremstilling af pyrido-(2,3-f)-(1,4)-diazepiner.

Country Status (30)

Country Link
US (1) US4110455A (ja)
JP (1) JPS5831351B2 (ja)
AR (3) AR217814A1 (ja)
AT (1) AT350056B (ja)
AU (1) AU504228B2 (ja)
BE (1) BE847952A (ja)
CA (1) CA1076111A (ja)
CH (1) CH630920A5 (ja)
CS (1) CS191181B2 (ja)
DD (1) DD128178A5 (ja)
DE (1) DE2649116A1 (ja)
DK (1) DK142324B (ja)
EG (1) EG12280A (ja)
ES (2) ES452971A1 (ja)
FI (1) FI62088C (ja)
FR (1) FR2330404A1 (ja)
GB (1) GB1562800A (ja)
HU (1) HU177422B (ja)
IL (1) IL50816A (ja)
IN (1) IN144289B (ja)
MX (1) MX4284E (ja)
NL (1) NL7612187A (ja)
NO (1) NO146470C (ja)
PL (2) PL113803B1 (ja)
PT (1) PT65787B (ja)
RO (2) RO77294A (ja)
SE (1) SE7612260L (ja)
SU (2) SU667137A3 (ja)
YU (1) YU269176A (ja)
ZA (1) ZA766620B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (en) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
TW201201813A (en) * 2010-03-31 2012-01-16 Arqule Inc Substituted benzo-pyrido-triazolo-diazepine compounds
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
RS58730B1 (sr) 2014-06-20 2019-06-28 Constellation Pharmaceuticals Inc Kristalni oblici 2-((4s)-6-(4-hlorofenil)-1-metil-4h-benzo[c]izoksazolo[4,5-e]azepin-4-il)acetamida

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
CS191181B2 (en) 1979-06-29
AU504228B2 (en) 1979-10-04
IL50816A (en) 1980-09-16
NO146470C (no) 1982-10-06
PT65787B (de) 1978-05-10
DK142324B (da) 1980-10-13
SU667137A3 (ru) 1979-06-05
FR2330404A1 (fr) 1977-06-03
AR216916A1 (es) 1980-02-15
FI763158A (ja) 1977-05-05
YU269176A (en) 1983-02-28
PL113803B1 (en) 1981-01-31
IN144289B (ja) 1978-04-22
PL193439A1 (pl) 1979-07-16
FR2330404B1 (ja) 1979-07-20
GB1562800A (en) 1980-03-19
BE847952A (fr) 1977-05-03
ES452971A1 (es) 1978-10-16
FI62088B (fi) 1982-07-30
JPS5831351B2 (ja) 1983-07-05
RO70245A (ro) 1981-06-30
NO146470B (no) 1982-06-28
PT65787A (de) 1976-12-01
EG12280A (en) 1978-12-31
IL50816A0 (en) 1977-01-31
FI62088C (fi) 1982-11-10
AR216915A1 (es) 1980-02-15
MX4284E (es) 1982-03-12
ES452969A1 (es) 1977-11-16
AU1931176A (en) 1978-05-11
ZA766620B (en) 1977-12-28
DE2649116A1 (de) 1977-05-18
JPS5259194A (en) 1977-05-16
RO77294A (ro) 1982-09-09
AR217814A1 (es) 1980-04-30
DD128178A5 (de) 1977-11-02
CA1076111A (en) 1980-04-22
CH630920A5 (de) 1982-07-15
US4110455A (en) 1978-08-29
HU177422B (en) 1981-10-28
ATA837275A (de) 1978-10-15
SU676165A3 (ru) 1979-07-25
NO763739L (ja) 1977-05-05
SE7612260L (sv) 1977-05-05
DK142324C (ja) 1981-03-02
NL7612187A (nl) 1977-05-06
AT350056B (de) 1979-05-10
PL118308B1 (en) 1981-09-30

Similar Documents

Publication Publication Date Title
DK142324C (ja)
CH599729A5 (ja)
BG22295A1 (ja)
BG22304A1 (ja)
BG22887A1 (ja)
CH581939A5 (ja)
CH587680A5 (ja)
CH588391A5 (ja)
CH588715A5 (ja)
CH589266A5 (ja)
CH589911A5 (ja)
CH590749A5 (ja)
CH590779A5 (ja)
CH591765A5 (ja)
CH592518A5 (ja)
CH592898A5 (ja)
CH593355A5 (ja)
CH593414A5 (ja)
CH593444A5 (ja)
CH593446A5 (ja)
CH594111A5 (ja)
CH594814A5 (ja)
CH594830A5 (ja)
CH594920A5 (ja)
CH594995A5 (ja)

Legal Events

Date Code Title Description
PBP Patent lapsed